Bayer Japan Aims At Sales Of ¥200B in 2013 Through Xarelto And Eylea
This article was originally published in PharmAsia News
Executive Summary
Bayer Japan hopes to increase sales by ¥10 billion to ¥200 billion in 2013 through the growth of its new products, the President Carsten Brunn announced at a Tokyo press conference April 3.